Burning Rock Biotech Limited (BNR)
USD 2.95
(0.34%)
USD 2.95
(0.34%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -602.77 Million CNY | 29.47% |
| 2022 | -854.66 Million CNY | 36.44% |
| 2021 | -1.34 Billion CNY | 27.26% |
| 2020 | -1.84 Billion CNY | -6807.17% |
| 2019 | -26.76 Million CNY | -114.96% |
| 2018 | 178.93 Million CNY | 57.12% |
| 2017 | 113.87 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -424.63 Million CNY | 23.3% |
| 2024 Q1 | -553.61 Million CNY | 8.15% |
| 2023 Q2 | -702.04 Million CNY | 6.65% |
| 2023 FY | -602.77 Million CNY | 29.47% |
| 2023 Q4 | -602.77 Million CNY | 2.34% |
| 2023 Q3 | -617.19 Million CNY | 12.09% |
| 2023 Q1 | -752.02 Million CNY | 12.01% |
| 2022 Q4 | -854.66 Million CNY | 9.87% |
| 2022 Q3 | -948.29 Million CNY | 11.86% |
| 2022 Q2 | -1.07 Billion CNY | 9.46% |
| 2022 FY | -854.66 Million CNY | 36.44% |
| 2022 Q1 | -1.18 Billion CNY | 11.63% |
| 2021 Q2 | -1.71 Billion CNY | 11.44% |
| 2021 Q4 | -1.34 Billion CNY | 11.57% |
| 2021 FY | -1.34 Billion CNY | 27.26% |
| 2021 Q3 | -1.52 Billion CNY | 11.46% |
| 2021 Q1 | -1.93 Billion CNY | -4.91% |
| 2020 Q1 | -293.82 Million CNY | -997.94% |
| 2020 Q4 | -1.84 Billion CNY | 8.31% |
| 2020 Q3 | -2.01 Billion CNY | 19.69% |
| 2020 FY | -1.84 Billion CNY | -6807.17% |
| 2020 Q2 | -2.51 Billion CNY | -754.28% |
| 2019 Q1 | 136.25 Million CNY | -22.7% |
| 2019 Q3 | -61.4 Million CNY | 0.0% |
| 2019 FY | -26.76 Million CNY | -114.96% |
| 2019 Q4 | -26.76 Million CNY | 56.42% |
| 2018 Q4 | 176.26 Million CNY | 0.0% |
| 2018 FY | 178.93 Million CNY | 57.12% |
| 2017 FY | 113.87 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -39.45 Million USD | -1427.862% |
| Applied DNA Sciences, Inc. | -5.91 Million USD | -10092.221% |
| Aspira Women's Health Inc. | -331 Thousand USD | -182006.344% |
| Biodesix, Inc. | 34.3 Million USD | 1856.994% |
| BioNexus Gene Lab Corp. | -5.79 Million USD | -10299.899% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | -48396.015% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | -48396.015% |
| Bionano Genomics, Inc. | 34.88 Million USD | 1828.032% |
| CareDx, Inc | -47.97 Million USD | -1156.403% |
| Check-Cap Ltd. | -24.75 Million USD | -2334.852% |
| Castle Biosciences, Inc. | -83.53 Million USD | -621.615% |
| DarioHealth Corp. | -7.54 Million USD | -7885.851% |
| Exact Sciences Corporation | 1.94 Billion USD | 130.922% |
| Fulgent Genetics, Inc. | -82.56 Million USD | -630.049% |
| Guardant Health, Inc. | 220.22 Million USD | 373.705% |
| ICON Public Limited Company | 3.56 Billion USD | 116.931% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | 222.031% |
| Illumina, Inc. | 1.21 Billion USD | 149.652% |
| Intelligent Bio Solutions Inc. | -5.43 Million USD | -10995.342% |
| iSpecimen Inc. | -2.14 Million USD | -27969.564% |
| Standard BioTools Inc. | 46.5 Million USD | 1396.117% |
| MDxHealth SA | 18.88 Million USD | 3291.803% |
| 23andMe Holding Co. | -141.37 Million USD | -326.373% |
| Medpace Holdings, Inc. | -103.32 Million USD | -483.363% |
| Myriad Genetics, Inc. | 88.1 Million USD | 784.191% |
| Mainz Biomed B.V. | 349.85 Thousand USD | 172391.95% |
| ENDRA Life Sciences Inc. | -2.43 Million USD | -24608.793% |
| NeoGenomics, Inc. | 269.19 Million USD | 323.92% |
| Neogen Corporation | 735.62 Million USD | 181.94% |
| Inotiv, Inc. | 382.14 Million USD | 257.732% |
| Natera, Inc. | -200.1 Million USD | -201.232% |
| OpGen, Inc. | 11.89 Million USD | 5168.768% |
| OPKO Health, Inc. | 230.68 Million USD | 361.299% |
| Psychemedics Corporation | 334 Thousand USD | 180570.659% |
| Prenetics Global Limited | -43.33 Million USD | -1290.893% |
| Prenetics Global Limited | -43.33 Million USD | -1290.893% |
| Precipio, Inc. | -386 Thousand USD | -156058.549% |
| Personalis, Inc. | -8.02 Million USD | -7413.987% |
| RadNet, Inc. | 1.14 Billion USD | 152.481% |
| Sera Prognostics, Inc. | -2.02 Million USD | -29710.682% |
| Sotera Health Company | 2.02 Billion USD | 129.761% |
| Neuronetics, Inc. | 2.79 Million USD | 21650.661% |
| Star Equity Holdings, Inc. | -15.33 Million USD | -3830.182% |
| Star Equity Holdings, Inc. | -15.33 Million USD | -3830.182% |
| Trinity Biotech plc | 63.73 Million USD | 1045.732% |
| T2 Biosystems, Inc. | 33.8 Million USD | 1882.874% |
| Twist Bioscience Corporation | -192.4 Million USD | -213.289% |
| Exagen Inc. | -12.77 Million USD | -4619.48% |